Clinical Trial

A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis

Name: A Study to Assess the Safety of HSK31858 in Participants With Non-Cystic Fibrosis Bronchiectasis — clinical trial record (NCT07616375)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

This is a phase III, single-arm, open-label, multicenter study to assess the safety of HSK31858 in non-cystic fibrosis bronchiectasis (NCFBE) participants.

Trial Details

NCT Number	NCT07616375
Lead Sponsor	Haisco Pharmaceutical Group Co., Ltd.
Conditions	Non-cystic Fibrosis Bronchiectasis
Enrollment	669 participants
Start Date	2025-09-28
Primary Completion	2029-01-10 (estimated)
Study Completion	2029-04-03 (estimated)
Updated on ClinicalTrials.gov	2026-06-01